Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target

V Infantino, A Santarsiero, P Convertini… - International journal of …, 2021 - mdpi.com
In order to meet the high energy demand, a metabolic reprogramming occurs in cancer cells.
Its role is crucial in promoting tumor survival. Among the substrates in demand, oxygen is …

Peptides and peptidomimetics as regulators of protein–protein interactions

AD Cunningham, N Qvit, D Mochly-Rosen - Current opinion in structural …, 2017 - Elsevier
Highlights•Protein–protein interactions are essential for almost all cell processes.•Peptides
are ideal candidates for targeting protein–protein interactions (PPIs).•We survey screening …

MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation

R Wu, J Zeng, J Yuan, X Deng, Y Huang… - The Journal of …, 2018 - Am Soc Clin Investig
Immune imbalance of T lymphocyte subsets is a hallmark of psoriasis, but the molecular
mechanisms underlying this aspect of psoriasis pathology are poorly understood. Here, we …

Affimer proteins are versatile and renewable affinity reagents

C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga… - Elife, 2017 - elifesciences.org
Molecular recognition reagents are key tools for understanding biological processes and are
used universally by scientists to study protein expression, localisation and interactions …

Targeting protein–protein interactions in the HIF system

SE Wilkins, MI Abboud, RL Hancock… - …, 2016 - Wiley Online Library
Animals respond to chronic hypoxia by increasing the levels of a transcription factor known
as the hypoxia‐inducible factor (HIF). HIF upregulates multiple genes, the products of which …

Sensitive and selective Affimer-functionalised interdigitated electrode-based capacitive biosensor for Her4 protein tumour biomarker detection

P Zhurauski, SK Arya, P Jolly, C Tiede… - Biosensors and …, 2018 - Elsevier
A novel Affimer-functionalised interdigitated electrode-based capacitive biosensor platform
was developed for detection and estimation of Her4, a protein tumour biomarker, in …

Alternative reagents to antibodies in imaging applications

R Bedford, C Tiede, R Hughes, A Curd… - Biophysical …, 2017 - Springer
Antibodies have been indispensable tools in molecular biology, biochemistry and medical
research. However, a number of issues surrounding validation, specificity and batch …

Generation of specific inhibitors of SUMO-1–and SUMO-2/3–mediated protein-protein interactions using Affimer (Adhiron) technology

DJ Hughes, C Tiede, N Penswick, AAS Tang… - Science …, 2017 - science.org
Because protein-protein interactions underpin most biological processes, developing tools
that target them to understand their function or to inform the development of therapeutics is …

Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3

C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific reports, 2017 - nature.com
Abstract Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the
reported values for serum GPC3 differ markedly between currently available kits. Here we …

Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy

J Li, W Xi, X Li, H Sun, Y Li - Bioorganic & Medicinal Chemistry, 2019 - Elsevier
Hypoxia is a common characteristic of many types of solid tumors and is associated with
tumor propagation, malignant progression, and resistance to anti-cancer therapy. HIF-1 …